TCI Wealth Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

TCI Wealth Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-887	Closed	-$3K	–	1735
2020 Q2	$3K	Hold	887	–	–	﹤0.01%	1008
2020 Q1	$3K	Hold	887	–	–	﹤0.01%	958
2019 Q4	$3K	Buy	887 +88	+11%	+$255	﹤0.01%	1083
2019 Q3	$2K	Buy	+799	New	+$2.14K	﹤0.01%	1204
2018 Q2	–	Sell	-295	Closed	-$1K	–	1690
2018 Q1	$1K	Buy	295 +77	+35%	+$210	﹤0.01%	1333
2017 Q4	$1K	Buy	+218	New	+$670	﹤0.01%	1359
2016 Q3	–	Sell	-180	Closed	-$1K	–	1469
2016 Q2	$1K	Sell	180 -176	-49%	-$587	﹤0.01%	1271
2016 Q1	$1K	Buy	+356	New	+$1.11K	﹤0.01%	1283

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TCI Wealth Advisors's PDLI Position: Q3 2020 in Review

TCI Wealth Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 887 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in PDLI in Q1 2016 and held it in 8 quarters. The position peaked at $3K in Q2 2020. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

TCI Wealth Advisors reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
TCI Wealth Advisors sold 887 PDL BioPharma, Inc. shares in Q3 2020, an estimated $3K.
TCI Wealth Advisors first reported a position in PDL BioPharma, Inc. in Q1 2016 and held it in 8 quarters.
TCI Wealth Advisors's PDL BioPharma, Inc. position peaked at $3K in Q2 2020.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on TCI Wealth Advisors's 13F filing for Q3 2020, filed 20 Oct 2020.